Literature DB >> 2384915

Bovine coronavirus mRNA replication continues throughout persistent infection in cell culture.

M A Hofmann1, P B Sethna, D A Brian.   

Abstract

The existence of viral mRNA replicons was demonstrated in cells infected with the bovine coronavirus by showing a minus-strand counterpart and a corresponding replicative intermediate for each subgenomic mRNA species. mRNA replication is thus a universal property of coronaviruses, since this is now the third coronavirus for which it has been demonstrated. During the acute phase of infection (first 48 h), minus and plus strands accumulated at the same rate initially, but maximal accumulation of minus strands peaked earlier than that for plus strands, indicating that minus- and plus-strand levels are differentially regulated. In addition, packaged (input) mRNAs appeared to serve as templates for their own early replication. mRNA replication continued throughout establishment and maintenance of persistent infection (studied for 120 days), which is consistent with our hypothesis that mRNA replication contributes mechanistically to virus persistence. A replication-defective (potentially interfering) species of RNA existed transiently (beginning at day 2 and ending before day 76 postinfection), but because of its transient nature it cannot be considered essential to the long-term maintenance of virus persistence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384915      PMCID: PMC247873     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Genomic RNA of the murine coronavirus JHM.

Authors:  H Wege; A Müller; V ter Meulen
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

2.  Synthesis of subgenomic mRNA's of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping.

Authors:  L Jacobs; W J Spaan; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

3.  Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length.

Authors:  M M Lai; C D Patton; S A Stohlman
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

4.  Characterization of two RNA polymerase activities induced by mouse hepatitis virus.

Authors:  P R Brayton; M M Lai; C D Patton; S A Stohlman
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  Genome of porcine transmissible gastroenteritis virus.

Authors:  D A Brian; D E Dennis; J S Guy
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

6.  Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis.

Authors:  S G Sawicki; D L Sawicki
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

7.  Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus.

Authors:  M M Lai; R S Baric; P R Brayton; S A Stohlman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Biological properties of avian coronavirus RNA.

Authors:  B Lomniczi
Journal:  J Gen Virol       Date:  1977-09       Impact factor: 3.891

9.  Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein genes.

Authors:  W Lapps; B G Hogue; D A Brian
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

10.  Presence of infectious polyadenylated RNA in coronavirus avian bronchitis virus.

Authors:  G Schochetman; R H Stevens; R W Simpson
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

View more
  75 in total

1.  Translation from the 5' untranslated region (UTR) of mRNA 1 is repressed, but that from the 5' UTR of mRNA 7 is stimulated in coronavirus-infected cells.

Authors:  S D Senanayake; D A Brian
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  A phylogenetically conserved hairpin-type 3' untranslated region pseudoknot functions in coronavirus RNA replication.

Authors:  G D Williams; R Y Chang; D A Brian
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Downstream sequences influence the choice between a naturally occurring noncanonical and closely positioned upstream canonical heptameric fusion motif during bovine coronavirus subgenomic mRNA synthesis.

Authors:  A Ozdarendeli; S Ku; S Rochat; G D Williams; S D Senanayake; D A Brian
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations.

Authors:  R J de Groot; R G van der Most; W J Spaan
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

5.  Regulation of relative abundance of arterivirus subgenomic mRNAs.

Authors:  Alexander O Pasternak; Willy J M Spaan; Eric J Snijder
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  The nucleocapsid protein gene of bovine coronavirus is bicistronic.

Authors:  S D Senanayake; M A Hofmann; J L Maki; D A Brian
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  Subgenomic messenger RNA amplification in coronaviruses.

Authors:  Hung-Yi Wu; David A Brian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-18       Impact factor: 11.205

8.  A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs.

Authors:  R G van der Most; P J Bredenbeek; W J Spaan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  A cis-acting function for the coronavirus leader in defective interfering RNA replication.

Authors:  R Y Chang; M A Hofmann; P B Sethna; D A Brian
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription.

Authors:  Y J Lin; C L Liao; M M Lai
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.